Open AccessSuccessful repeated treatment with high dose cyclophosphamide and autologous blood stem cell transplantation in CIDP
Author(s) -
Hans Axelson,
Gunnar Öberg,
Håkan Askmark
Publication year - 2009
Publication title -
bmj case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.231
H-Index - 26
ISSN - 1757-790X
DOI - 10.1136/bcr.09.2008.0927
Subject(s) - medicine , chronic inflammatory demyelinating polyneuropathy , cyclophosphamide , transplantation , autologous stem cell transplantation , weakness , surgery , immunology , chemotherapy , antibody
Chronic inflammatory demyelinating polyneuropathy (CIDP) is characterised by the occurrence of symmetrical weakness and sensory impairment in arms and legs. The course is relapsing or chronic and progressing. CIDP is considered to be an autoimmune disease, which is supported by the beneficial response to immunomodulating therapies in most patients. We report on a patient with CIDP who has been in remission for more than 3 years after treatment with high dose cyclophosphamide and autologous blood stem cell transplantation in CIDP on two occasions.